The role of growth factor genes in the development of uterine fibroids combined with endometrial hyperplasia


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Materials and methods. The study included 982 women: 193 women with uterine fibroids combined with endometrial hyperplasia and 789 healthy controls. Five polymorphic loci of growth factor genes were chosen for the study: EGFc.-38M>G rs4444903, TGFp-1 c.-1347T>C rs1800469, IGF1 c.*2716GM rs6214, VEGFc.-958C>T rs833061, FGFR2 c.109+906T>C rs2981582. The study was carried out using the polymerase chain reaction method. Results. Polymorphic loci were found to be associated with the development of uterine fibroids combined with endometrial hyperplasia. Genotype CC rs2981582 FGFR2 increases the risk of developing uterine fibroids combined with endometrial hyperplasia (OR=1.38). The combination of alleles A rs4444903 EGF and C rs1800469 TGFfi-1 is also a risk factor for the development of the disease (OR=1.50). The combination of G rs4444903 EGF, C rs1800469 TGFfi-1, G rs6214 IGF1, and T rs2981582 FGFR2 can play a protective role in the development of the disease (OR=0.59). These polymorphisms have a significant regulatory potential and affect the expression level of eight different genes; they are located in the areas of exonic splicing enhancers and they are the binding sites of transcription factors. Conclusion. Polymorphic loci of the genes PGR c.1415-11113G>T rs1042838, ESR1 c.*1029T>C rs3798577, ESR1 c.453-397T>Crs2234693, ESR1 c.453-35M>Grs9340799 are associated with the development of uterine fibroids combined with endometrial hyperplasia.

Full Text

Restricted Access

About the authors

Oksana B. Altukhova

Belgorod National Research University

Email: kristalinka@yandex.ru
MD, associate professor, Department of obstetrics and gynecology, Medical Faculty

Viktor E. Radzinsky

Peoples' Friendship University of Russia

Email: radzinskiy-ve@rudn.ru
MD, professor, Head of the Department of obstetrics and gynecology, Medical Faculty

Irina S. Polyakova

Belgorod National Research University

Email: polyakovairina@bsu.edu.ru
associate professor, Department of Biomedical Disciplines, Medical Faculty

Mikhail I. Churnosov

Belgorod National Research University

Email: churnosov@bsu.edu.ru
MD, professor, Head of the Department of Biomedical Disciplines, Medical Faculty

References

  1. Адамян Л.В., ред. Сочетанные доброкачественные опухоли и гиперпластические процессы матки (миома, аденомиоз, гиперплазия эндометрия). Проект клинических рекомендаций по ведению больных. М.; 2015. 92 с. [Adamyan L.V., ed. Combined benign tumors and hyperplastic processes of the uterus (fibroids, adenomyosis, endometrial hyperplasia). Draft clinical guidelines for the management of patients. M.; 2015. 92p. (in Russian)].
  2. Киселев В.И., Сидорова И.С., Унанян А.Л., Муйжнек Е.Л. Гиперпластические процессы органов женской репродуктивной системы: теория и практика. М.: МЕДПРАКТИКА-М; 2010. 468 с.
  3. McWilliams M.M., Chennathukuzhi V.M. Recent advances in uterine fibroid etiology. Semin. Reprod. Med. 2017; 35(2): 181-9. https:// dx.doi.org/10.1055/s-0037-1599090.
  4. Пономаренко И.В., Полоников А.В., Чурносов М.И. Гиперпластические процессы эндометрия: этиопатогенез, факторы риска, полиморфизм генов-кандидатов. Акушерство и гинекология. 2019; 1: 13-8. [Ponomarenko I.V., Polonikov A.V., Churnosov M.I. Endometrial hyperplastic processes: etiopathogenesis, risk factors, polymorphism of candidate genes. Akusherstvo I Ginekologiya/Obstetrics and Gynecology. 2019; 1: 13-8. (in Russian)]. https:// dx.doi.org/10.18565/aig.2019.1.13-18.
  5. Пономаренко И.В., Чурносов М.И. Современные представления об этиопатогенезе и факторах риска лейомиомы матки. Акушерство и гинекология. 2018; 8: 27-32. https:// dx.doi.org/10.18565/aig.2018.8.27-32.
  6. Гарашова М.А. Частота встречаемости и сочетанности неопластических процессов гениталий в постменопаузальном периоде. Вестник современной клинической медицины. 2019; 12(2): 28-32. [Garashova M.A. The frequency of occurrence and combination of neoplastic genital processes in the postmenopausal period. Bulletin of modern clinical medicine. 2019; 12(2): 28-32 (in Russian)]. https://dx.doi.org/10.20969/VSKM.2019.12(2).28-32.
  7. rbo A., Arnes M, Vereide A., Straume B. Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel-impregnated intrauterine system or oral progestogens. BJOG. 2016; 123(9): 1512-9. https://dx.doi.org/10.1111/ 1471-0528.13763.
  8. Kim J.J., Kurita Т., Bulun S.E. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr. Rev. 2013; 34(1): 130-62. https://dx.doi.org/10.1210/er.2012-1043.
  9. Krivoshei I.V., Altuchova O.B., Golovchenko O.V., Polonikov A.V., Churnosov M.I. Genetic factors of hysteromyoma. Research Journal of Medical Sciences. 2015; 9(4): 182-5. https://dx.doi.org/10.3923/rjmsci.2015.182.185.
  10. Пономаренко И.В., Полоников А.В., Чурносов М.И. Полиморфные локусы гена LHCGR ассоциированы с развитием миомы матки. Акушерство и гинекология. 2018; 10: 86-91. [Ponomarenko I.V., Polonikov A.V., Churnosov M.I. Polymorphic loci of the LHCGR gene are associated with the development of uterine fibroids. Akusherstvo I Ginekologiya/Obstetrics and Gynecology. 2018; 10: 86-91 (in Russian)]. https://dx.doi.org/10.18565/ aig.2018.10.86-91.
  11. Пономаренко И.В., Полоников А.В., Чурносов М.И. Ассоциация полиморфизма rs4986938 гена ESR2 с развитием гиперплазии эндометрия. Акушерство и гинекология. 2019; 4: 66-72. [Ponomarenko I.V., Polonikov A.V., Churnosov M.I. Association of ESR2 rs4986938 polymorphism with the development of endometrial hyperplasia. Akusherstvo i Ginekologiya/ Obstetrics and Gynecology. 2019; (4): 66-72. (in Russian)]. https:// dx.doi.org/10.18565/aig.2019.4.66-72.
  12. Churnosov M.I., Altuchova O.B., Demakova N.A., Batlutskaya I.V., PolonikovA.V. Associations of cytokines genetic variants with myomatous knots sizes. Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2014; 5(6): 1344-7.
  13. Лицова А.О., Малышкина А.И., Воронин Д.Н. Особенности системной и локальной продукции цитокинов у женщин с миомой матки различных темпов роста. Российский иммунологический журнал. 2012; 6(2): 105-6. [Litsova A.O., Malishkina A.I., Voronin D.N. Features of systemic and local production of cytokines in women with uterine fibroids of various growth rates. Russian immunological journal. 2012; 6(2): 105-6 (in Russian)].
  14. Chuang T.D., Luo X., Panda H. miR-93/106b and their host gene, МСМ7 are differentially expressed in leiomyomas and functionally target F3 and IL-8. Мol. Endocrinol. 2012; 26(6): 1028-42. https://dx.doi.org/10.1210/ me.2012-1075.
  15. Сорокина И.Н., Рудых Н.А., Безменова И.Н., Полякова И.С. Популяционногенетические характеристики и генетико-эпидемиологическое исследование ассоциаций генов-кандидатов с мультифакториальными заболеваниями. Научные результаты биомедицинских исследований. 2018; 4(4): 20-30. [Sorokina I.N., Rudykh N.A., Bezmenova I.N., Polyakova I.S. Population genetic characteristics and genetic epidemiological research of candidate genes associations with multifactorial diseases. Research Results in Biomedicine. 2018; 4(4): 20-30 (in Russian)]. https://dx.doi.org/10.18413/2313-8955-2018-4-4-0-3.
  16. Пономаренко И.В. Отбор полиморфных локусов для анализа ассоциаций при генетико-эпидемиологических исследованиях. Научный результат. Медицина и фармация. 2018; 4(2): 40-54. [Ponomarenko I.V. Selection of polymorphic loci for association analysis in genetic-epidemiological studies. Research Result. Medicine and Pharmacy. 2018; 4(2): 40-54 (in Russian)]. https://dx.doi.org/10.18413/2313-8955-2018-4-2-0-5.
  17. Favorov A.V., Andreewski T.V., Sudomoina M.A., Favorova O.O., Parmigiani M.F. A Markov chain Monte Carlo technique for identification of combinations of allelic variants underlying complex diseases in humans. Genetics. 2005; 171(4): 2113-21. https://dx.doi.org/10.1534/ genetics.105.048090.
  18. Lvovs D, Favorova O.O, Favorov A.V. A polygenic approach to the study of polygenic diseases. Acta Naturae. 2012; 4(3): 59-71.
  19. Гнатенко Д.А., Копанцев Е.П., Свердлов Е.Д. Роль сигнального пути FGR/ FGFR в канцерогенезе поджелудочной железы. Биомедицинская химия. 2016; 62(6): 622-9. [Gnatenko D.A., Kopantsev E.P., Sverdlov E.D. The role of the signaling pathway FGR/FGFR in pancreatic cancer. Biomedical chemistry. 2016; 62(6): 622-9. (in Russian)]. https://dx.doi.org/10.18097/ PBMC20166206622.
  20. Cui F. Variants of FGRF2 and their associations with breast cancer risc: a HUGE systematic rewiew and meta-analysis. Breast Cancer Res. Treat. 2016; 155(2): 313-35. https://dx.doi.org/10.1007/s10549-015-3670-2.
  21. Lecanda J. Transforming growth factor-β, estrogen, and progesterone converge on the regulation of p27Kip1 in the normal and malignant endometrium. Сancer Res. 2007; 67(3): 1007-18. https://dx.doi.org/10.1158/0008-5472. CAN-06-0235.
  22. Fragoso J.M. The Т29С (rs1800470) polymorphism of the transforming growth factor-P1 (TGF-P1) gene is associated with restenosis after coronary stenting in Мexican patients. Exp. Мol. Pathol. 2015; 98(1): 13-7. https://dx.doi. org/10.1016/j.yexmp.2014.11.007.
  23. Бурменская О.В., Байрамова Г.Р., Непша О.С., Донников А.Е. Цитокиновый профиль иммунокомпетентных клеток влагалища при хроническом рецидивирующем вульвовагинальном кандидозе. Уральский медицинский журнал. 2011; 3: 44-9. [Burmenskaya O.V., Bayramova G.R., Nepsha O.S., Donnikov A.E. Cytokine mRNA profiles of immunocompetent vaginal cells of women with chronic recurrent vulvovaginal candidiasis. Uralskiy Medical journal. 2011; 3: 44-9. (in Russian)].
  24. Солодовников а Н.Г., Ниаури Д. А. Роль цитокинов в развитии наружного генитального эндометриоза (обзор литературы). Вестник Санкт-Петербургского университета. Серия: Медицина. 2006; 2: 115-22. [Solodovnikova N.G., Niauri D.A. The role of cytokines in the development of external genital endometriosis: (literature review). Bulletin of St. Petersburg University. Series Medicine. 2006; 2: 115-22. (in Russian)].
  25. Меньшикова Н.С. Функциональный полиморфизм генов иммуносупрессорных цитокинов при наружном генитальном эндометриозе. Мать и дитя в Кузбассе. 2013; 1: 24-6. [Menshikova N.S. Functional polymorphism of immunosuppressive cytokine genes in case of external genital endometriosis. Mother and child in Kuzbass. 2013; 1: 24-6. (in Russian)].
  26. Привалова Е.Е. Процессы цитокин- и нитроксидергической регуляции при наружном генитальном эндометриозе, ассоциированным с бесплодием. Вестник Южно-Уральского государственного университета. Серия: Образование, здравоохранение, физическая культура. 2009; 20: 58-61. [Privalova E.E. The processes of cytokinnitroxergic regulation in external genital endometriosis associated with infertility. Bulletin of SUSU. 2009; 20: 58-61. (in Russian)].
  27. Адамян Л.В., Салимова Д.Ф., Кондратович Л.М. Патогенетические аспекты эндометриоз-ассоциированного бесплодия. Проблемы репродукции. 2015; 21(6): 90-6. [Adamyan L.V., Salimova D.F., Kondratovich L.M. Pathogenetic aspects of endometriosis-associated infertility. Reproduction problems. 2015; 21(6): 90-6. (in Russian)].
  28. Гуляева Л.Ф., Красильников С.Э. Молекулярные механизмы канцерогенеза эндометрия. Бюллетень Восточно-Сибирского научного центра СО РАМН. 2012; 3(1): 110-5. [Gulyaeva L.F., Krasilnikov S.E. Molecular mechanisms of carcinogenesis of the endometrium. Bulletin of the East Siberian Scientific Center of the SB RAMS. 2012; 3(1): 110-5. (in Russian)].
  29. Крылова Ю.С., Кветной И.М. Айлмазян Э.К. Рецептивность эндометрия: молекулярные механизмы регуляции имплантации. Журнал акушерства и женских болезней. 2013; 62(2): 63-74. [Krylova Yu.S., Kvetnoy I.M. Ailmazyan E.K. Endometrial receptivity: molecular mechanisms for the regulation of implantation. Journal of Obstetrics and Women's Diseases. 2013; 62(2): 63-74. (in Russian)].

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies